This chapter explores the interest of pharmaceutical companies, particularly Pfizer, in the weight loss pill market. It delves into Pfizer's plans to acquire C-Gen and the challenges of developing effective weight loss pills compared to injections. The chapter also discusses the market for injectables and the potential role of pills in addressing supply issues.
Bloomberg News Health Reporter Madison Muller explains how Pfizer’s second weight-loss setback this year is a warning sign that breaking into the lucrative obesity market isn’t going to be easy. Cory Klippsten, CEO at Swan Bitcoin, shares his crypto outlook for 2024. Benjamin Wolkon, Founding Partner at MUUS Climate Partners, talks about investing in climate funding. Bloomberg News Mexico Business Reporter Amy Stillman provides the details of her Businessweek Magazine story Chinese Sales Swamp Competition in Soaring Mexican Car Market. And we Drive to the Close with Carol Schleif, CIO at BMO Family Office.
Hosts: Carol Massar and Bailey Lipschultz. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.